Medically reviewed by Matthew Wosnitzer, MD Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also ...

For more than a century, maps of the brain have been based on how brain tissue looks under the microscope. These anatomical ...

When the six tiny spacecraft of NASA's SunRISE (Sun Radio Interferometer Space Experiment) mission settle into their orbits ...

For years, China has been able to use its monopoly over critical minerals to influence international policy. On Jan. 14, Trump ordered trade officials to delay tariffs on rare earths and to negotiate ...

A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...

India's talent ecosystem is rapidly evolving with global education playing a key role. This synergy enhances innovation and ...

Omeros Corporation, an innovative biotechnology company, announced that the US Food and Drug Administration (FDA) has approved Yartemlea (narsoplimab-wuug) for the treatment of hematopoietic stem cell ...

Nearly six in 10 new airports handle fewer than five flights daily, exposing the gap between infrastructural ambition and ...

IgA nephropathy is a type of kidney disease that is typically treated with various medicines and lifestyle changes. Learn more about IgA nephropathy treatment here.

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA ® (narsoplimab-wuug) for the treatment of hematopoietic ...

For more than a century, maps of the brain have been based on how brain tissue looks under the microscope. These anatomical maps divide the brain into regions according to structural variations in the ...

It's been a long time coming: Four years after Omeros came up short in its bid to gain an FDA approval for stem cell transplant drug narsoplimab, the Seattle biotech has finally scored its ...